Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iduna Fichtner

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Journal of Biomedical Nanotechnology|June 16, 2016
Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin LiposomesAndrea Orthmann, Lisa Peiker, Iduna Fichtner, et al.
Molecular Cancer Therapeutics|January 24, 2007
Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter-regulated tumor necrosis factor-alpha expressionWolfgang Walther, Franziska Arlt, Iduna Fichtner, et al.
Proteomics|December 31, 2005
Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistanceVladimir Besada, Maylin Diaz, Michael Becker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 25, 2011
Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shellMarcelo Calderón, Pia Welker, Kai Licha, et al.
Journal of Pharmaceutical Sciences|December 17, 2009
Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier modelAndrea Orthmann, Reiner Zeisig, Tilen Koklic, et al.
Cytotherapy|November 26, 2009
Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in miceErika Deak, Brigitte Rüster, Lisa Keller, et al.
Stem Cells (Dayton, Ohio)|March 14, 2003
Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID miceAndreas Nitsche, Ilse Junghahn, Stefanie Thulke, et al.
Archiv Der Pharmazie|October 8, 2005
Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigenFelix Kratz, Ahmed Mansour, Jens Soltau, et al.
International Journal of Oncology|September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer modelsTomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Molecular Cancer Therapeutics|January 20, 2005
Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAMMichael Becker, Anette Sommer, Jörn R Krätzschmar, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Journal of Biomedical Nanotechnology|June 16, 2016
Improved Treatment of MT-3 Breast Cancer and Brain Metastases in a Mouse Xenograft by LRP-Targeted Oxaliplatin LiposomesAndrea Orthmann, Lisa Peiker, Iduna Fichtner, et al.
Molecular Cancer Therapeutics|January 24, 2007
Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter-regulated tumor necrosis factor-alpha expressionWolfgang Walther, Franziska Arlt, Iduna Fichtner, et al.
Proteomics|December 31, 2005
Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistanceVladimir Besada, Maylin Diaz, Michael Becker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 25, 2011
Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shellMarcelo Calderón, Pia Welker, Kai Licha, et al.
Journal of Pharmaceutical Sciences|December 17, 2009
Impact of membrane properties on uptake and transcytosis of colloidal nanocarriers across an epithelial cell barrier modelAndrea Orthmann, Reiner Zeisig, Tilen Koklic, et al.
Cytotherapy|November 26, 2009
Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in miceErika Deak, Brigitte Rüster, Lisa Keller, et al.
Stem Cells (Dayton, Ohio)|March 14, 2003
Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID miceAndreas Nitsche, Ilse Junghahn, Stefanie Thulke, et al.
Archiv Der Pharmazie|October 8, 2005
Development of albumin-binding doxorubicin prodrugs that are cleaved by prostate-specific antigenFelix Kratz, Ahmed Mansour, Jens Soltau, et al.
International Journal of Oncology|September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer modelsTomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Molecular Cancer Therapeutics|January 20, 2005
Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAMMichael Becker, Anette Sommer, Jörn R Krätzschmar, et al.
Pageof 12